|
    ABBV U.S.: NYSE
    ABBVUS
    After Hours
    Last Updated: Oct 27, 2021 6:45 p.m. EDT Delayed quote

    $ 108.71

    0.31 0.29%
    After Hours Volume: 352.13K
    Close Chg Chg %
    $108.40 -1.09 -1.00%
    Advanced Charting
    Volume: 4.88M 65 Day Avg: 7.16M
    68% vs Avg
    108.17 Day Range 109.72
    79.11 52 Week Range 121.53

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABBV Overview

    Performance

    5 Day
    • -0.01%
    1 Month
    • -0.40%
    3 Month
    • -8.56%
    YTD
    • 1.17%
    1 Year
    • 34.68%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 21 Full Ratings

    Recent News

    Read full story

    AbbVie Inc. stock outperforms competitors despite losses on the day

    Read full story

    AbbVie Inc. stock underperforms Tuesday when compared to competitors despite daily gains

    Read full story

    AbbVie Inc. stock underperforms Monday when compared to competitors

    Go to video

    Perspectives on Prices from Beverly Hills to Europe

    Read full story

    AbbVie Inc. stock outperforms market on strong trading day

    Read full story

    AbbVie and More Companies That Are Expected to Raise Their Dividends

    Read full story

    AbbVie Inc. stock outperforms competitors on strong trading day

    Read full story

    AbbVie Inc. stock underperforms Wednesday when compared to competitors despite daily gains

    Read full story

    AbbVie Inc. stock rises Tuesday, still underperforms market

    Read full story

    AbbVie Inc. stock underperforms Monday when compared to competitors

    Read full story

    AbbVie Inc. stock rises Friday, still underperforms market

    AbbVie Gets CHMP Positive Opinion for Risankizumab in Psoriatic Arthritis

    Read full story

    AbbVie Inc. stock rises Thursday, still underperforms market

    Read full story

    AbbVie Inc. stock falls Wednesday, underperforms market

    Read full story

    AbbVie Inc. stock falls Tuesday, underperforms market

    Read full story

    AbbVie Inc. stock falls Monday, underperforms market

    Read full story

    AbbVie Inc. stock outperforms competitors on strong trading day

    Read full story

    AbbVie Inc. stock underperforms Thursday when compared to competitors despite daily gains

    AbbVie Sees Positive Results in Rinvoq Studies

    Read full story

    AbbVie Inc. stock outperforms competitors despite losses on the day

    Groesbeck Investment Management Corp Buys Digital Realty Trust Inc, AbbVie Inc, ONEOK Inc, ...

    on GuruFocus.com

    McLean Asset Management Corp Buys Dimensional U.S. Equity ETF, Dimensional U.S. ...

    on GuruFocus.com

    Recovery in Drugs Sales to Aid AbbVie's (ABBV) Q3 Earnings

    on Zacks.com

    Healthcare ETFs in Focus as Q3 Earnings Unfold

    on Zacks.com

    Alethea Capital Management, Llc Buys Old Dominion Freight Line Inc, Broadridge Financial ...

    on GuruFocus.com

    AbbVie Takes Another Step Toward Its Post-Humira Future

    on Motley Fool

    3 Stocks You Can Still Buy on Sale in a Ridiculously Expensive Market

    on Motley Fool

    First Business Financial Services, Inc. Buys Amazon. ...

    on GuruFocus.com

    Montis Financial, LLC Buys iShares Core Dividend Growth ETF, General Dynamics Corp, Sells ...

    on GuruFocus.com

    7 High-Yield Stock Gems for Income-Obsessed Investors

    on InvestorPlace.com

    Cohen Lawrence B Buys Palo Alto Networks Inc, Deere, Hubbell Inc, Sells Verizon Communications ...

    on GuruFocus.com

    LeJeune Puetz Investment Counsel LLC Buys Victoria

    on GuruFocus.com

    AbbVie (ABBV) to Report Q3 Earnings: What's in the Cards?

    on Zacks.com

    The 7 Best Stocks to Buy to Profit From the Rich

    on InvestorPlace.com

    Was Atea Pharmaceutical's Flop Predictable?

    on Motley Fool

    Buy This Great High-Yield Dividend Stock?

    on Zacks.com

    AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

    on Zacks.com

    5 Buy-Rated Blue Chips Are Raising Their Dividends This Week

    on 247WallSt.com

    What Could These Clinical Results Mean for AbbVie's Shareholders?

    on Motley Fool

    Ramsey Quantitative Systems Buys Tesla Inc, Netflix Inc, Merck Inc, Sells Berkshire Hathaway ...

    on GuruFocus.com

    AbbVie Inc.

    AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson -1.21% $436.33B
    Pfizer Inc. -1.35% $244.23B
    Novo Nordisk A/S Series B -0.79% kr.1.56T
    AstraZeneca PLC ADR 0.00% $192.34B
    AstraZeneca PLC -0.10% £139.47B
    Moderna Inc. -1.41% $139.56B
    Amgen Inc. -1.01% $118.5B
    CSL Ltd. 1.01% $134.88B
    Gilead Sciences Inc. -1.42% $84.92B
    BioNTech SE ADR -4.66% $70.91B
    Competitor Data Provided ByCapital Cube Logo